Windsor, Canada

Christina Armstrong


Average Co-Inventor Count = 5.0

ph-index = 1


Loading Chart...

Title: Christina Armstrong: Innovator in Pharmaceutical Formulations

Introduction

Christina Armstrong is a notable inventor based in Windsor, California. She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on the encapsulation of naproxen in soft gel dosage units. Her innovative work aims to enhance the stability, concentration, and bioavailability of this important nonsteroidal anti-inflammatory drug (NSAID).

Latest Patents

Christina Armstrong holds a patent for her invention titled "Pharmaceutical Formulations Of Naproxen For Soft Gel Encapsulation And Combinations Thereof." This invention relates to a naproxen formulation that is suitable for encapsulation into a soft gel dosage unit. It increases the stability and concentration of naproxen while also improving its bioavailability. The formulation allows for the inclusion of other active pharmaceutical ingredients and provides a method for adjusting pH values without additional process steps. This highly concentrated formulation enables a reduction in the fill volume or dosage unit size, or an increase in the concentration of the active pharmaceutical ingredient per dosage form.

Career Highlights

Christina Armstrong is currently employed at Accucaps Industries Limited, where she continues to develop innovative pharmaceutical solutions. Her work has been instrumental in advancing the field of drug formulation, particularly in the area of soft gel encapsulation.

Collaborations

Christina collaborates with her coworker, John Lopez, to further enhance the research and development of pharmaceutical formulations. Their combined expertise contributes to the success of their projects and the advancement of their company's goals.

Conclusion

Christina Armstrong is a pioneering inventor whose work in pharmaceutical formulations has the potential to significantly impact the industry. Her innovative approaches to drug encapsulation demonstrate her commitment to improving patient outcomes through enhanced medication delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…